TY - JOUR
T1 - Electrocardiogram screening for aortic valve stenosis using artificial intelligence
AU - Cohen-Shelly, Michal
AU - Attia, Zachi I.
AU - Friedman, Paul A.
AU - Ito, Saki
AU - Essayagh, Benjamin A.
AU - Ko, Wei Yin
AU - Murphree, Dennis H.
AU - Michelena, Hector I.
AU - Enriquez-Sarano, Maurice
AU - Carter, Rickey E.
AU - Johnson, Patrick W.
AU - Noseworthy, Peter A.
AU - Lopez-Jimenez, Francisco
AU - Oh, Jae K.
N1 - Publisher Copyright:
© 2021 Published on behalf of the European Society of Cardiology. All rights reserved.
PY - 2021/8/7
Y1 - 2021/8/7
N2 - Aims?: Early detection of aortic stenosis (AS) is becoming increasingly important with a better outcome after aortic valve replacement in asymptomatic severe AS patients and a poor outcome in moderate AS. We aimed to develop artificial intelligence-enabled electrocardiogram (AI-ECG) using a convolutional neural network to identify patients with moderate to severe AS. Methods and results?: Between 1989 and 2019, 258 607 adults [mean age 63 ± 16.3 years; women 122 790 (48%)] with an echocardiography and an ECG performed within 180 days were identified from the Mayo Clinic database. Moderate to severe AS by echocardiography was present in 9723 (3.7%) patients. Artificial intelligence training was performed in 129 788 (50%), validation in 25 893 (10%), and testing in 102 926 (40%) randomly selected subjects. In the test group, the AI-ECG labelled 3833 (3.7%) patients as positive with the area under the curve (AUC) of 0.85. The sensitivity, specificity, and accuracy were 78%, 74%, and 74%, respectively. The sensitivity increased and the specificity decreased as age increased. Women had lower sensitivity but higher specificity compared with men at any age groups. The model performance increased when age and sex were added to the model (AUC 0.87), which further increased to 0.90 in patients without hypertension. Patients with false-positive AI-ECGs had twice the risk for developing moderate or severe AS in 15 years compared with true negative AI-ECGs (hazard ratio 2.18, 95% confidence interval 1.90-2.50). Conclusion?: An AI-ECG can identify patients with moderate or severe AS and may serve as a powerful screening tool for AS in the community.
AB - Aims?: Early detection of aortic stenosis (AS) is becoming increasingly important with a better outcome after aortic valve replacement in asymptomatic severe AS patients and a poor outcome in moderate AS. We aimed to develop artificial intelligence-enabled electrocardiogram (AI-ECG) using a convolutional neural network to identify patients with moderate to severe AS. Methods and results?: Between 1989 and 2019, 258 607 adults [mean age 63 ± 16.3 years; women 122 790 (48%)] with an echocardiography and an ECG performed within 180 days were identified from the Mayo Clinic database. Moderate to severe AS by echocardiography was present in 9723 (3.7%) patients. Artificial intelligence training was performed in 129 788 (50%), validation in 25 893 (10%), and testing in 102 926 (40%) randomly selected subjects. In the test group, the AI-ECG labelled 3833 (3.7%) patients as positive with the area under the curve (AUC) of 0.85. The sensitivity, specificity, and accuracy were 78%, 74%, and 74%, respectively. The sensitivity increased and the specificity decreased as age increased. Women had lower sensitivity but higher specificity compared with men at any age groups. The model performance increased when age and sex were added to the model (AUC 0.87), which further increased to 0.90 in patients without hypertension. Patients with false-positive AI-ECGs had twice the risk for developing moderate or severe AS in 15 years compared with true negative AI-ECGs (hazard ratio 2.18, 95% confidence interval 1.90-2.50). Conclusion?: An AI-ECG can identify patients with moderate or severe AS and may serve as a powerful screening tool for AS in the community.
KW - Aortic stenosis
KW - Artificial intelligence
KW - Convolutional neural network
KW - ECG
UR - http://www.scopus.com/inward/record.url?scp=85107930966&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85107930966&partnerID=8YFLogxK
U2 - 10.1093/eurheartj/ehab153
DO - 10.1093/eurheartj/ehab153
M3 - Article
C2 - 33748852
AN - SCOPUS:85107930966
SN - 0195-668X
VL - 42
SP - 2885
EP - 2896
JO - European heart journal
JF - European heart journal
IS - 30
ER -